105 related articles for article (PubMed ID: 1204255)
21. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
Takahashi T; Irie RF; Nishinaka Y; Hoon DS
Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
[TBL] [Abstract][Full Text] [Related]
22. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
23. Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood.
Burns GF; Good MF; Riglar C; Bartlett PF; Crapper RM; Mackay IR
Clin Exp Immunol; 1984 Aug; 57(2):487-94. PubMed ID: 6331928
[TBL] [Abstract][Full Text] [Related]
24. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
25. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials.
Zaritskaya L; Shafer-Weaver KA; Gregory MK; Strobl SL; Baseler M; Malyguine A
J Immunother; 2009; 32(2):186-94. PubMed ID: 19238018
[TBL] [Abstract][Full Text] [Related]
26. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
27. Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells.
Nunn ME; Herberman RB
J Natl Cancer Inst; 1979 Apr; 62(4):765-71. PubMed ID: 285291
[TBL] [Abstract][Full Text] [Related]
28. [In vitro humeral serum cytotoxic reactions in melanoma].
Korosteleva TA; Veresova OV; Khachaturyan LM
Vopr Onkol; 1979; 25(9):12-4. PubMed ID: 483712
[TBL] [Abstract][Full Text] [Related]
29. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
30. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
Sulé-Suso J; Arienti F; Melani C; Colombo MP; Parmiani G
Eur J Immunol; 1995 Oct; 25(10):2737-42. PubMed ID: 7589065
[TBL] [Abstract][Full Text] [Related]
31. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.
Griffiths MM; Smith CB; Ward JR; Klauber MR
J Clin Invest; 1976 Sep; 58(3):613-22. PubMed ID: 956390
[TBL] [Abstract][Full Text] [Related]
33. [Humoral antitumor cytotoxins in patients with melanoma of the skin].
Korosteleva TA; Veresova OV; Khachaturian LM
Vopr Onkol; 1975; 21(5):61-3. PubMed ID: 1210146
[TBL] [Abstract][Full Text] [Related]
34. Cellular immune defects in patients with melanoma involving interleukin-2-activated lymphocyte cytotoxicity and a serum suppressor factor.
Balch CM; Itoh K; Tilden AB
Surgery; 1985 Aug; 98(2):151-7. PubMed ID: 3875156
[TBL] [Abstract][Full Text] [Related]
35. IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.
Guarini A; Gansbacher B; Cronin K; Fierro MT; Foa R
Cytokines Mol Ther; 1995 Mar; 1(1):57-64. PubMed ID: 9384664
[TBL] [Abstract][Full Text] [Related]
36. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors.
de Vries JE; Meyering M; van Dongen A; Rümke P
Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313
[TBL] [Abstract][Full Text] [Related]
37. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
Currie GA; Lejeune F; Fairley GH
Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic lymphocytes in melanoma patients.
Faucault JP; Bernard JP; Potier JC; Lecacheux C
Int J Cancer; 1972 May; 9(3):567-76. PubMed ID: 4676747
[No Abstract] [Full Text] [Related]
39. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
Ferrone S; Pellegrino MA
J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
[TBL] [Abstract][Full Text] [Related]
40. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
